|
1.
|
|
12 p, 2.9 MB |
Advances and Pitfalls of Specialized Pain Care through Public and Private Health Care Providers in Catalonia and the Balearic Islands : A Physician's Survey
/
Medel, Javier (Hospital Universitari Vall d'Hebron) ;
Serrano Afonso, Ancor (Hospital Universitari de Bellvitge. Unitat del Dolor) ;
Batet, Carme (Hospital de Sant Joan Despí Moisès Broggi) ;
Lorente, Lluis (Institut de Medicina i Cirurgia de Barcelona. Unitat del Dolor) ;
Bella, Susana (Hospital Universitari Sant Joan de Reus. Unitat del Dolor) ;
Ferrandiz, Marta (Institut d'Investigació Biomèdica Sant Pau) ;
Monerris, María del Mar (Institut Germans Trias i Pujol) ;
Boada, Sergi (Hospital Universitari Joan XXIII. Unitat del Dolor) ;
Villoria, Jesus (Medicxact. Departament de Disseny i Biometria) ;
Ribera, Maria Victoria (Hospital Universitari Vall d'Hebron) ;
Montes, Antonio (Hospital Del Mar. Unitat del Dolor) ;
Videla, Sebastián (Institut d'Investigació Biomèdica de Bellvitge. Universitat de Barcelona. Unitat de Farmacologia. Departament de Patologia i Terapèutica Experimental. Facultat de Medicina i Ciències de la Salut)
Optimal diagnosis and treatment of pain require a multidisciplinary approach that demands considerable coordination and forethought. A cross-sectional physician survey based on an online questionnaire was carried out to assess the adoption of multidisciplinary working patterns, compare the public and private models, and provide an update on the resources and organization of specialized pain care in Catalonia and the Balearic Islands. [...]
2022 -  10.1155/2022/4077139
Pain Research and Management, Vol. 2022 (2022) , p. 4077139
|
|
|
2.
|
|
16 p, 387.5 KB |
Prevalence and Characterization of Psychological Trauma in Patients with Fibromyalgia : A Cross-Sectional Study
/
Gardoki-Souto, Itxaso (Parc de Salut MAR de Barcelona) ;
Redolar-Ripoll, Diego (Universitat Oberta de Catalunya) ;
Fontana-McNally, Marta (Parc de Salut MAR de Barcelona) ;
Hogg, Bridget (Parc de Salut MAR de Barcelona) ;
Castro, María José (Parc de Salut MAR de Barcelona) ;
Blanch Rubió, Josep (Parc de Salut MAR de Barcelona) ;
Ojeda, Fabiola (Parc de Salut MAR de Barcelona) ;
Solanes, Aleix (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Radua, Joaquim (King's College London) ;
Valiente-Gómez, Alicia (Parc de Salut MAR de Barcelona) ;
Cirici, Roser (Parc de Salut MAR de Barcelona) ;
Pérez Solà, Víctor (Parc de Salut MAR de Barcelona) ;
Amann, Benedikt L (Parc de Salut MAR de Barcelona) ;
Moreno Alcázar, Ana (Parc de Salut MAR de Barcelona) ;
Universitat Autònoma de Barcelona
Preliminary evidence suggests that psychological trauma, especially childhood trauma, is a risk factor for the onset of fibromyalgia (FM). The main objective of this study consisted of evaluating the prevalence and detailed characteristics of psychological trauma in a sample of patients with FM, the chronology of trauma across the lifespan, and its clinical symptoms. [...]
2022 - 10.1155/2022/2114451
Pain Research & Management, Vol. 2022 (november 2022)
|
|
|
3.
|
|
8 p, 799.5 KB |
Periaqueductal gray matter echogenicity as a marker of migraine chronification : a case control study
/
Vilas, Dolores (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Rubio, Sara (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Gea, Mireia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Ríos, José (Universitat Autònoma de Barcelona) ;
Ispierto, Lourdes (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Hernández-Pérez, María (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Paré-Curell, Martí (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Millán, Mònica (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Dorado Bouix, Laura (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Migraine is one of the most prevalent and disabling medical diseases in the world. The periaqueductal gray matter and the red nucleus play an important role in its pathogenesis. Our aim was to evaluate the echogenicity of the periaqueductal gray matter and the red nucleus in patients with migraine, by means of transcranial ultrasound. [...]
2023 - 10.1186/s10194-023-01576-3
Journal of headache and pain, Vol. 24 (april 2023)
|
|
|
4.
|
|
13 p, 1.9 MB |
A study of differential microRNA expression profile in migraine : the microMIG exploratory study
/
Gallardo, Víctor J.. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Gómez-Galván, J. B. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Asskour, L. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Torres-Ferrús, Marta (Hospital Universitari Vall d'Hebron) ;
Alpuente, Alicia (Hospital Universitari Vall d'Hebron) ;
Caronna, Edoardo (Hospital Universitari Vall d'Hebron) ;
Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron) ;
Universitat Autònoma de Barcelona
Several studies have described potential microRNA (miRNA) biomarkers associated with migraine, but studies are scarcely reproducible primarily due to the heterogeneous variability of participants. Increasing evidence shows that disease-related intrinsic factors together with lifestyle (environmental factors), influence epigenetic mechanisms and in turn, diseases. [...]
2023 - 10.1186/s10194-023-01542-z
Journal of headache and pain, Vol. 24 (february 2023)
|
|
|
5.
|
|
|
6.
|
|
8 p, 761.9 KB |
MAB-MIG : registry of the spanish neurological society of erenumab for migraine prevention
/
Belvís, Roberto (Institut d'Investigació Biomèdica Sant Pau) ;
Irimia, Pablo (Clínica Universidad de Navarra) ;
Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
González-Oria, Carmen (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Cano, Antonio (Hospital de Mataró. Consorci Sanitari del Maresme) ;
Viguera, Javier (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ;
Sánchez, Belén (Hospital Quirónsalud Zaragoza) ;
Molina, Francisco (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ;
Beltrán, Isabel (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
Oterino, Agustín (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ;
Cuadrado-Godia, Elisa (Hospital del Mar (Barcelona, Catalunya)) ;
Gómez-Camello, Angel (Hospital Universitario San Cecilio (Granada)) ;
Alberte-Woodward, Miguel (Hospital Universitario Lucus Augusti (Lugo)) ;
Jurado, Carmen (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ;
Oms, Teresa (Hospital Dos de Maig) ;
Ezpeleta, David (Hospital Quironsalud Madrid) ;
de Terán, Javier Díaz (Hospital Universitario La Paz (Madrid)) ;
Morollón Sánchez-Mateos, Noemí (Hospital Universitari Dexeus (Barcelona, Catalunya)) ;
Latorre, Germán (Hospital Universitario de Fuenlabrada ( Madrid)) ;
Torres-Ferrús, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Alpuente, Alicia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Lamas, Raquel (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Toledano, Carlos (Clínica Universidad de Navarra) ;
Leira, Rogelio (Complejo Hospitalario Universitario de Santiago de Compostela) ;
Santos, Sonia (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ;
Del Rio, Margarita Sanchez (Clínica Universidad de Navarra) ;
Universitat Autònoma de Barcelona
Erenumab was approved in Europe for migraine prevention in patients with ≥ 4 monthly migraine days (MMDs). In Spain, Novartis started a personalized managed access program, which allowed free access to erenumab before official reimbursement. [...]
2021 - 10.1186/s10194-021-01267-x
Journal of headache and pain, Vol. 22 (july 2021)
|
|
|
7.
|
|
11 p, 1005.5 KB |
Cortical metabolic and structural differences in patients with chronic migraine. An exploratory 18 FDG-PET and MRI study
/
Torres-Ferrús, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Pareto, Deborah (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Gallardo, Víctor J.. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Cuberas-Borrós, Gemma (Hospital Universitari Vall d'Hebron) ;
Alpuente, Alicia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Caronna, Edoardo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Vila-Balló, Adrià (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Lorenzo-Bosquet, Carles (Hospital Universitari Vall d'Hebron) ;
Castell-Conesa, Joan (Hospital Universitari Vall d'Hebron) ;
Rovira, Alex (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
To describe interictal brain structural and metabolic differences between patients with episodic migraine (EM), chronic migraine (CM) and healthy controls (HC). This is an exploratory study including right-handed age-matched women with EM, CM and HC. [...]
2021 - 10.1186/s10194-021-01289-5
Journal of headache and pain, Vol. 22 (july 2021)
|
|
|
8.
|
|
13 p, 575.7 KB |
Relevant factors for neurologists to define effectiveness of migraine preventive drugs and take decisions on treatment. My-LIFE European Delphi survey
/
Pozo-Rosich, Patricia (Universitat Autònoma de Barcelona) ;
Gil-Gouveia, Raquel (Hospital da Luz (Lisboa, Portugal)) ;
Donnet, Anne (Timone Hospital) ;
Poole, Anne-Christine (Private Practice: Oslo Headache Centre) ;
Gendolla, Astrid (Private Practice: Essen) ;
Afridi, Shazia (Guy's and St Thomas' NHS Trust) ;
Sanchez-De la Rosa, Rainel (Novartis Pharma AG) ;
Terwindt, Gisela M. (Leiden University Medical Center) ;
Tassorelli, Cristina (University of Pavia)
Clinical guidelines agree that preventive treatment should be considered in patients with uncontrolled migraine despite acute medications or patients with ≥4 migraine days per month. However, the criteria to define the effectiveness of treatment and the factors that inform the decision to (dis)continue it are not clearly defined in clinical practice. [...]
2021 - 10.1002/ejp.1831
European Journal of Pain (Regne Unit), Vol. 25 (july 2021) , p. 2177-2189
|
|
|
9.
|
|
10 p, 963.4 KB |
The neurologic pain signature responds to nonsteroidal anti-inflammatory treatment vs placebo in knee osteoarthritis
/
López-Solà, Marina (Universitat de Barcelona. Departament de Medicina) ;
Pujol Nuez, Jesús (Centro de Investigación Biomédica en Red de Salud Mental) ;
Monfort, Jordi (Hospital del Mar (Barcelona, Catalunya)) ;
Deus Yela, Juan (Universitat Autònoma de Barcelona. Departament de Psicologia Clínica i de la Salut) ;
Blanco Hinojo, Laura (Centro de Investigación Biomédica en Red de Salud Mental) ;
Harrison, Ben J. (The University of Melbourne. Department of Psychiatry) ;
Wager, Tor D. (Dartmouth College. Department of Psychological and Brain Sciences)
Supplemental Digital Content is Available in the Text. fMRI-based measures, validated for nociceptive pain, respond to acute osteoarthritis pain, are not sensitive to placebo, and are mild-to-moderately sensitive to naproxen. [...]
2022 - 10.1097/PR9.0000000000000986
Pain reports, Vol. 7 (february 2022)
|
|
|
10.
|
|
10 p, 1.9 MB |
InterMiG : international differences in the therapeutic approach to migraine patients in specialized headache centers
/
Gago-Veiga, Ana Beatriz (Instituto de Investigación Hospital Universitario de la Princesa) ;
Huhn, J-I (Praxis Gendolla) ;
Latysheva, Nina (I.M.Sechenov First Moscow State Medical University) ;
Vieira Campos, A. (Instituto de Investigación Hospital Universitario de la Princesa) ;
Torres-Ferrús, Marta (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Alpuente, Alicia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Sacco, Simona (University of L'Aquila) ;
Frattale, I (University of L'Aquila) ;
Ornello, R. (University of L'Aquila) ;
Ruscheweyh, Ruth (Ludwig Maximilians University Munich) ;
Marques, I. B. (Hospital da Luz (Lisboa, Portugal)) ;
Gryglas-Dworak, A. (Private Headache Clinic (Polònia)) ;
Stark, C. (Austin Health) ;
Gallardo, Víctor J.. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Pozo-Rosich, Patricia (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Universitat Autònoma de Barcelona
There is currently a wide therapeutic arsenal for migraine patients, without a single first-line preventive drug and we choose the different available alternatives taking into account comorbidities, national guidelines, previous treatments and personal experiences. [...]
2021 - 10.1186/s10194-021-01258-y
Journal of headache and pain, Vol. 22 (may 2021)
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
